Humacyte Inc (NASDAQ:HUMA) currently has a daily average trading volume of 4.46M but it saw 4848154 shares traded in last market. With a market cap of 372.29M USD, the company’s current market price of $2.40 came rising about 2.56 while comparing to the previous closing price of $2.34. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.97 and as low as $1.15.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which resumed the stock as “Buy” in its note to investors issued on May 14, 2025, recommending a price target of $4 for it. H.C. Wainwright issued its recommendations for the stock as it initiated the price target for the stock is $6.
Over the week, HUMA’s stock price is moving 26.98% up while it is 63.27% when we observe its performance for the past one month. Year-to-date it is -52.48% down and over the past year, the stock is showing a downside performance of -66.01%.
Currently, Humacyte Inc’s total number of outstanding shares is 155.12M with 20.16% of that held by the insiders while 39.84% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -70.48% and return on equity (ROE) at -257.38%. Stock’s beta reads 1.86. Stock has a price to book (P/B) ratio of 10.33 while price to sale or P/S ratio amounts to 715.94. Its return on asset (ROA) is -49.40% on average.
